Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2026-01-01 @ 10:30 PM
Study NCT ID:
NCT06990204
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-05-25
First Post:
2025-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia)
Sponsor:
Gedeon Richter Plc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-28
First Submit QC Date:
None
Study First Post Date:
2025-05-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-17
Last Update Post Date:
2025-05-25
Last Update Post Date Type:
ACTUAL